litespark-004: 36 month follow-up of belzutifan in von hippel-lindau syndrome
Published 1 year ago • 154 plays • Length 9:35Download video MP4
Download video MP3
Similar videos
-
13:17
belzutifan for von hippel-lindau syndrome
-
1:59
next steps for belzutifan for von hippel-lindau syndrome
-
2:44
novel von hippel-lindau syndrome therapies inhibiting hif-2α
-
2:52
litespark-004: esa use in vhl disease-associated rcc
-
4:44
pathophysiology and management of von hippel-lindau syndrome
-
5:20
treatment strategies for von hippel-lindau syndrome
-
2:09
promising real-world outcomes of belzutifan in vhl-associated tumors
-
1:55
belzutifan real-world vs clinical trial data: comparing efficacy and safety in vhl-associated tumors
-
1:59
what is von hippel-lindau syndrome?
-
5:30
systemic therapy with belzutifan approved for von hippel lindau-associated cancers
-
1:48
dr. jonasch on next steps with mk-6482 in von hippel-lindau disease–associated rcc
-
22:38
von hippel-lindau disease: clinical update and new drug therapy
-
40:40
belzutifan for vhl-associated tumors: a molecules to medicine success story—elaine t. lam, md, facp
-
3:58
nancy rose spector's rare disease story
-
0:59
#vhl syndrome #vhl disease #phakomatoses #von hippel lindau disease
-
29:08
fda approval of belzutifan | eric jonasch, md
-
2:15
mk-6482 shows promise in von hippel-lindau disease-associated renal cell carcinoma
-
16:26
learn about ocular von hippel-lindau disease with dr. henry wiley
-
3:01
what is von hippel-lindau disease?